» Articles » PMID: 24853936

The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2014 May 24
PMID 24853936
Citations 521
Authors
Affiliations
Soon will be listed here.
Abstract

The collapse of neural networks important for memory and cognition, including death of neurons and degeneration of synapses, causes the debilitating dementia associated with Alzheimer's disease (AD). We suggest that synaptic changes are central to the disease process. Amyloid beta and tau form fibrillar lesions that are the classical hallmarks of AD. Recent data indicate that both molecules may have normal roles at the synapse, and that the accumulation of soluble toxic forms of the proteins at the synapse may be on the critical path to neurodegeneration. Further, the march of neurofibrillary tangles through brain circuits appears to take advantage of recently described mechanisms of transsynaptic spread of pathological forms of tau. These two key phenomena, synapse loss and the spread of pathology through the brain via synapses, make it critical to understand the physiological and pathological roles of amyloid beta and tau at the synapse.

Citing Articles

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease.

Cai Y, Kanyo J, Wilson R, Bathla S, Cardozo P, Tong L Nat Aging. 2025; .

PMID: 40065072 DOI: 10.1038/s43587-025-00823-3.


The interplay between age at menopause and synaptic integrity on Alzheimer's disease risk in women.

Wood Alexander M, Honer W, Saloner R, Galea L, Bennett D, Rabin J Sci Adv. 2025; 11(10):eadt0757.

PMID: 40043118 PMC: 11881898. DOI: 10.1126/sciadv.adt0757.


Physical Activity, Alzheimer Plasma Biomarkers, and Cognition.

Kim S, Shin D, Ham H, Kim Y, Gu Y, Kim H JAMA Netw Open. 2025; 8(3):e250096.

PMID: 40042844 PMC: 11883494. DOI: 10.1001/jamanetworkopen.2025.0096.


From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.

Xu X, Su J, Zhu R, Li K, Zhao X, Fan J Mol Cancer. 2025; 24(1):63.

PMID: 40033282 PMC: 11874780. DOI: 10.1186/s12943-025-02240-x.


Multi-targeted benzylpiperidine-isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies.

Negi N, Ayyannan S, Tripathi R J Comput Aided Mol Des. 2025; 39(1):10.

PMID: 40021503 DOI: 10.1007/s10822-025-00588-2.


References
1.
Karch C, Jeng A, Goate A . Calcium phosphatase calcineurin influences tau metabolism. Neurobiol Aging. 2012; 34(2):374-86. PMC: 3879081. DOI: 10.1016/j.neurobiolaging.2012.05.003. View

2.
van HARREVELD A, Fifkova E . Swelling of dendritic spines in the fascia dentata after stimulation of the perforant fibers as a mechanism of post-tetanic potentiation. Exp Neurol. 1975; 49(3):736-49. DOI: 10.1016/0014-4886(75)90055-2. View

3.
Eckert A, Schulz K, Rhein V, Gotz J . Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol. 2010; 41(2-3):107-14. PMC: 2876263. DOI: 10.1007/s12035-010-8109-5. View

4.
Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

5.
Boutajangout A, Ingadottir J, Davies P, Sigurdsson E . Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem. 2011; 118(4):658-67. PMC: 3366469. DOI: 10.1111/j.1471-4159.2011.07337.x. View